Brolucizumab
0 sources
Brolucizumab
Summary
Brolucizumab is a type of chemical entity[1]. Brolucizumab ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (42 views/month).[2]
Key Facts
- Brolucizumab's instance of is recorded as type of chemical entity[3].
- Brolucizumab's physically interacts with is recorded as vascular endothelial growth factor A[4].
- Brolucizumab is a type of chemical compound[5].
- Brolucizumab's World Health Organisation international non-proprietary name is recorded as {'lang': 'en', 'text': 'brolucizumab'}[6].
- Brolucizumab's subject has role is recorded as monoclonal antibody[7].
- Brolucizumab's has active ingredient is recorded as Brolucizumab[8].
Why It Matters
Brolucizumab ranks in the top 6% of type_of_chemical_entity entities by monthly Wikipedia readership (42 views/month).[2] Brolucizumab has Wikipedia articles in 6 language editions, a strong signal of global cultural recognition.[9] Brolucizumab is known by 8 alternative names across languages and contexts.[10]